The Interaction of a Histidine-Rich Protein Hpn with the Membrane Mimics: Implications for Pathologic Roles of Hpn in Helicobacter pylori

Helicobacter

Volumn 19, Issue 2, 2014, Pages 129-135

  Zhou, Qinglu ^a   Qi, Shuang ^b   Sun, Xuesong ^c   Ge, Ruiguang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Generalized polarization; Helicobacter pylori; Hpn; Membrane

Indexed keywords

BACTERIAL PROTEIN; HPN PROTEIN; UNCLASSIFIED DRUG; CALCEIN; FLUORESCEIN DERIVATIVE; HISTIDINE-RICH PROTEINS; HPN PROTEIN, HELICOBACTER PYLORI; LIPID BILAYER; MEMBRANE PROTEIN; POLITEF; PROTEIN; PROTEIN BINDING; TRIFLUOROETHANOL;

ALPHA HELIX; ARTICLE; BACTERIAL MEMBRANE; CALCEIN RELEASE ASSAY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HELICOBACTER PYLORI; LAURDAN AND PRODAN GENERALIZED POLARIZATION; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY; BIOSYNTHESIS; CELL MEMBRANE; CHEMISTRY; FLUORESCENCE POLARIZATION; HELICOBACTER INFECTION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE;

BACTERIAL PROTEINS; CELL MEMBRANE; FLUORESCEINS; FLUORESCENCE POLARIZATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIPID BILAYERS; MEMBRANE PROTEINS; POLYTETRAFLUOROETHYLENE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEINS; TRIFLUOROETHANOL;

EID: 84896842140     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12109     Document Type: Article

References (28)

1. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-33.
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK, Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
4. Marshall BJ. The discovery that Helicbacter pylori, a spiral bacterium, caused peptic ulcer disease. In: Marshall BJ, ed. Helicbacter pylori Pioneers. Carlton: Blackwell, 2002;165-202.
5. Ge R, Chen Z, Zhou Q. The actions of bismuth in the treatment of Helicobacter pylori infections: an update. Metallomics 2012;4:239-43.
6. Gilbert JV, Ramakrishna J, Sunderman FW Jr, Wright A, Plaut AG. Protein Hpn: cloning and characterization of a histidine-rich metal-binding polypeptide in Helicobacter pylori and Helicobacter mustelae. Infect Immun 1995;63:2682-8.
7. 2+ storage in Helicobacter pylori. Biochem J 2006;393:285-93.
8. Ge R, Zhang Y, Sun X, Watt RM, He QY, Huang JD, Wilcox DE, Sun H. Thermodynamic and kinetic aspects of metal binding to the histidine-rich protein, Hpn. J Am Chem Soc 2006;128:11330-1.
9. Mobley HL, Garner RM, Chippendale GR, Gilbert JV, Kane AV, Plaut AG. Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions. Helicobacter 1999;4:162-9.
10. Ge R, Sun H. Bioinorganic chemistry of bismuth and antimony: target sites of metallodrugs. Acc Chem Res 2007;40:267-74.
11. Ge R, Sun X. The in vivo functions of a histidine-rich protein Hpn in Helicobacter pylori: linking gastric and Alzheimer's diseases together? Med Hypotheses 2011;77:788-90.
12. Ge R, Sun X, Wang D, Zhou Q, Sun H. Histidine-rich protein Hpn from Helicobacter pylori formas amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells. Biochim Biophys Acta 2011;1813:1422-7.
13. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003;26:267-98.
14. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005;437:257-61.
15. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003;300:486-9.
16. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004;279:46363-6.
17. Dowhan W. Molecular basis for membrane phospholipid diversity: why are there so many lipids? Annu Rev Biochem 1997;66:199-232.
18. Li H, Li F, Sun H, Qian ZM. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter. Biochem J 2003;372(Pt 3):757-66.
19. Chen Z, Zhou Q, Ge R. Inhibition of fumarase by bismuth(III): implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori. Biometals 2012;25:95-102.
20. Sreerama N, Woody RW. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem 2000;287:252-60.
21. Maltsev AV, Bystryak S, Galzitskaya OV. The role of beta-amyloid peptide in neurodegenerative diseases. Ageing Res Rev 2011;10:440-52.
22. Takano K. Amyloid beta conformation in aqueous environment. Curr Alzheimer Res 2008;5:540-7.
23. Uversky VN. Intrinsically disordered proteins and their environment: effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding. Protein J 2009;28:305-25.
24. Parasassi T, Krasnowska EK, Bagatolli L, Gratton E. Laurdan and prodan as polarity-sensitive fluorescent membrane probes. J Fluoresc 1998;8:365-73.
25. Dupiereux I, Zorzi W, Lins L, Brasseur R, Colson P, Heinen E, Elmoualij B. Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity. Biochem Biophys Res Commun 2005;331:894-901.
26. Pillot T, Lins L, Groethals M, Vanloo B, Baert J, Vandekerckhove J, Rosseneu M, Brasseur R. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J Mol Biol 1997;274:381-93.
27. Pillot T, Goethals M, Vanloo B, Talussot C, Brasseur R, Vandekerckhove J, Rosseneu M, Lins L. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J Biol Chem 1996;271:28757-65.
28. Brasseur R. Tilted peptides: a motif for membrane destabilization (hypothesis). Mol Membr Biol 2000;17:31-40.